BIOMAT Database Logo BIOMAT Database Logo

Busulfan-Dependent Hepatotoxicity of Antithymocyte Globulin Formulations During Conditioning for Hematopoietic Stem Cell Transplantation. 2018

Walter J F M van der Velden, and Esther C de Weerd-de Jong, and Anton F J de Haan, and Nicole M A Blijlevens
Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: walter.vandervelden@radboudumc.nl.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002066 Busulfan An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Busulphan,Busulfan Wellcome,Busulfex,Glyzophrol,Myelosan,Mylecytan,Myleran,Myléran,n-Butane-1,3-di(methylsulfonate),Wellcome, Busulfan
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D000961 Antilymphocyte Serum Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION. ATGAM,Antilymphoblast Globulins,Antilymphocyte Antibodies,Antilymphocyte Globulin,Lymphocytotoxic Antibodies,Anti-Thymocyte Globulin,Antilymphocyte Immunoglobulin,Antithymocyte Globulin,Antithymoglobulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine),Pressimmune,Anti Thymocyte Globulin,Anti-Thymocyte Globulins,Antibodies, Antilymphocyte,Antibodies, Lymphocytotoxic,Antibody, Antilymphocyte,Antibody, Lymphocytotoxic,Antilymphoblast Globulin,Antilymphocyte Antibody,Antilymphocyte Globulins,Antilymphocyte Immunoglobulins,Antilymphocyte Serums,Antithymocyte Globulins,Antithymoglobulins,Globulin, Anti-Thymocyte,Globulin, Antilymphoblast,Globulin, Antilymphocyte,Globulin, Antithymocyte,Globulins, Anti-Thymocyte,Globulins, Antilymphoblast,Globulins, Antilymphocyte,Globulins, Antithymocyte,Immunoglobulin, Antilymphocyte,Immunoglobulins, Antilymphocyte,Lymphocyte Immune Globulin, Anti Thymocyte Globulin,Lymphocytotoxic Antibody,Serum, Antilymphocyte,Serums, Antilymphocyte
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic

Related Publications

Walter J F M van der Velden, and Esther C de Weerd-de Jong, and Anton F J de Haan, and Nicole M A Blijlevens
Long-term results of allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
January 2011, Neoplasma,
Walter J F M van der Velden, and Esther C de Weerd-de Jong, and Anton F J de Haan, and Nicole M A Blijlevens
Does antithymocyte globulin have a place in reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation?
January 2012, Hematology. American Society of Hematology. Education Program,
Walter J F M van der Velden, and Esther C de Weerd-de Jong, and Anton F J de Haan, and Nicole M A Blijlevens
Comparison of 2 Different Doses of Antithymocyte Globulin in Conditioning Regimens for Haploidentical Hematopoietic Stem Cell Transplantation.
January 2022, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation,
Walter J F M van der Velden, and Esther C de Weerd-de Jong, and Anton F J de Haan, and Nicole M A Blijlevens
[Antithymocyte globulin for GVHD prophylaxis in allogeneic hematopoietic stem cell transplantation].
January 2021, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Walter J F M van der Velden, and Esther C de Weerd-de Jong, and Anton F J de Haan, and Nicole M A Blijlevens
Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
October 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Walter J F M van der Velden, and Esther C de Weerd-de Jong, and Anton F J de Haan, and Nicole M A Blijlevens
Tecelac as antithymocyte globulin in conditioning for childhood allogeneic stem cell transplantation.
June 2002, Bone marrow transplantation,
Walter J F M van der Velden, and Esther C de Weerd-de Jong, and Anton F J de Haan, and Nicole M A Blijlevens
Accidental busulfan overdose during conditioning for stem cell transplantation.
January 2005, Bone marrow transplantation,
Walter J F M van der Velden, and Esther C de Weerd-de Jong, and Anton F J de Haan, and Nicole M A Blijlevens
The impact of different doses of antithymocyte globulin conditioning on immune reconstitution upon hematopoietic stem cell transplantation.
December 2021, Transplant immunology,
Walter J F M van der Velden, and Esther C de Weerd-de Jong, and Anton F J de Haan, and Nicole M A Blijlevens
Characterization of Viral Infections after Antithymocyte Globulin-Based Conditioning in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
September 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Walter J F M van der Velden, and Esther C de Weerd-de Jong, and Anton F J de Haan, and Nicole M A Blijlevens
Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantation.
October 2005, Journal of pediatric hematology/oncology,
Copied contents to your clipboard!